Trial intelligence / Profile preview

Comparison of Hemostatic Agents and Tourniquet in Abdominal Myomectomy

NCT04595812Phase 4Unknown

Sponsor
Cairo University
Start
Nov 2020
Primary completion
Aug 2022
Modality
Peptides
01

Overview

A Phase 4 trial of carbetocin in uterine leiomyoma, sponsored by Cairo University. Status: unknown.

02

Drugs

carbetocin
03

Conditions

uterine leiomyoma

Beyond the preview

Go deeper on NCT04595812.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04595812.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call